Tetraphase Pharmaceuticals

Shares of Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) have lost nearly 75 percent of value year-to-date. The Vetr crowd downgraded Tetraphase to a rating of four stars out of a possible five. Despite a downgrade, the Vetr crowd still sees upside in Tetraphase's stock as 66 percent...